nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—CYP2D6—breast cancer	0.107	0.389	CbGaD
Morphine—CYP3A4—breast cancer	0.0916	0.333	CbGaD
Morphine—ABCB1—breast cancer	0.0763	0.278	CbGaD
Morphine—UGT2B7—Epirubicin—breast cancer	0.0344	0.0875	CbGbCtD
Morphine—UGT1A1—Irinotecan—breast cancer	0.0289	0.0736	CbGbCtD
Morphine—CYP2C8—Lapatinib—breast cancer	0.022	0.0561	CbGbCtD
Morphine—ABCB1—Toremifene—breast cancer	0.0204	0.052	CbGbCtD
Morphine—CYP3A4—Exemestane—breast cancer	0.0177	0.045	CbGbCtD
Morphine—CYP2C8—Raloxifene—breast cancer	0.0167	0.0425	CbGbCtD
Morphine—CYP2D6—Idarubicin—breast cancer	0.016	0.0406	CbGbCtD
Morphine—CYP3A4—Letrozole—breast cancer	0.015	0.0382	CbGbCtD
Morphine—ABCB1—Lapatinib—breast cancer	0.0149	0.0379	CbGbCtD
Morphine—CYP3A4—Anastrozole—breast cancer	0.0134	0.0341	CbGbCtD
Morphine—CYP3A4—Toremifene—breast cancer	0.0122	0.0312	CbGbCtD
Morphine—CYP3A4—Fulvestrant—breast cancer	0.0114	0.029	CbGbCtD
Morphine—CYP2C8—Tamoxifen—breast cancer	0.011	0.0281	CbGbCtD
Morphine—CYP3A4—Thiotepa—breast cancer	0.0101	0.0258	CbGbCtD
Morphine—CYP3A4—Ixabepilone—breast cancer	0.00928	0.0236	CbGbCtD
Morphine—CYP3A4—Lapatinib—breast cancer	0.00893	0.0227	CbGbCtD
Morphine—CYP2C8—Paclitaxel—breast cancer	0.00858	0.0218	CbGbCtD
Morphine—ABCB1—Vinorelbine—breast cancer	0.00827	0.021	CbGbCtD
Morphine—CYP2C8—Fluorouracil—breast cancer	0.00813	0.0207	CbGbCtD
Morphine—CYP2D6—Vinorelbine—breast cancer	0.00779	0.0198	CbGbCtD
Morphine—ABCB1—Tamoxifen—breast cancer	0.00746	0.019	CbGbCtD
Morphine—ABCB1—Mitoxantrone—breast cancer	0.00728	0.0185	CbGbCtD
Morphine—CYP2D6—Tamoxifen—breast cancer	0.00703	0.0179	CbGbCtD
Morphine—CYP3A4—Raloxifene—breast cancer	0.00677	0.0172	CbGbCtD
Morphine—ABCB1—Gemcitabine—breast cancer	0.00643	0.0164	CbGbCtD
Morphine—ABCB1—Paclitaxel—breast cancer	0.00581	0.0148	CbGbCtD
Morphine—ABCB1—Irinotecan—breast cancer	0.00573	0.0146	CbGbCtD
Morphine—ABCB1—Vinblastine—breast cancer	0.0051	0.013	CbGbCtD
Morphine—CYP3A4—Vinorelbine—breast cancer	0.00495	0.0126	CbGbCtD
Morphine—CYP2D6—Vinblastine—breast cancer	0.0048	0.0122	CbGbCtD
Morphine—CYP3A4—Tamoxifen—breast cancer	0.00447	0.0114	CbGbCtD
Morphine—CYP3A4—Mitoxantrone—breast cancer	0.00436	0.0111	CbGbCtD
Morphine—ABCB1—Docetaxel—breast cancer	0.0042	0.0107	CbGbCtD
Morphine—CYP3A4—Paclitaxel—breast cancer	0.00348	0.00886	CbGbCtD
Morphine—CYP3A4—Irinotecan—breast cancer	0.00343	0.00874	CbGbCtD
Morphine—ABCB1—Doxorubicin—breast cancer	0.00313	0.00797	CbGbCtD
Morphine—CYP3A4—Vinblastine—breast cancer	0.00305	0.00777	CbGbCtD
Morphine—ABCB1—Methotrexate—breast cancer	0.00303	0.00772	CbGbCtD
Morphine—CYP2D6—Doxorubicin—breast cancer	0.00295	0.00751	CbGbCtD
Morphine—CYP3A4—Docetaxel—breast cancer	0.00252	0.00641	CbGbCtD
Morphine—UGT2B15—mammary gland—breast cancer	0.00213	0.139	CbGeAlD
Morphine—CYP3A4—Doxorubicin—breast cancer	0.00188	0.00477	CbGbCtD
Morphine—OPRL1—female reproductive system—breast cancer	0.00103	0.0667	CbGeAlD
Morphine—OPRL1—adrenal gland—breast cancer	0.001	0.0651	CbGeAlD
Morphine—UGT1A8—endocrine gland—breast cancer	0.00089	0.0579	CbGeAlD
Morphine—UGT2B15—female reproductive system—breast cancer	0.000882	0.0573	CbGeAlD
Morphine—OPRL1—endocrine gland—breast cancer	0.000868	0.0564	CbGeAlD
Morphine—UGT2B4—endocrine gland—breast cancer	0.000828	0.0538	CbGeAlD
Morphine—UGT1A3—endocrine gland—breast cancer	0.000794	0.0516	CbGeAlD
Morphine—UGT2B15—endocrine gland—breast cancer	0.000746	0.0485	CbGeAlD
Morphine—OPRL1—lymph node—breast cancer	0.0006	0.039	CbGeAlD
Morphine—UGT2B7—female reproductive system—breast cancer	0.000539	0.035	CbGeAlD
Morphine—CYP2C8—mammary gland—breast cancer	0.000524	0.0341	CbGeAlD
Morphine—OPRK1—female reproductive system—breast cancer	0.000506	0.0329	CbGeAlD
Morphine—UGT2B7—endocrine gland—breast cancer	0.000456	0.0296	CbGeAlD
Morphine—UGT1A1—endocrine gland—breast cancer	0.000388	0.0252	CbGeAlD
Morphine—Galantamine—ACHE—breast cancer	0.000358	0.11	CrCbGaD
Morphine—OPRM1—endocrine gland—breast cancer	0.000305	0.0198	CbGeAlD
Morphine—CYP2C8—endometrium—breast cancer	0.000262	0.017	CbGeAlD
Morphine—CYP2C8—pituitary gland—breast cancer	0.000237	0.0154	CbGeAlD
Morphine—CYP2C8—female reproductive system—breast cancer	0.000217	0.0141	CbGeAlD
Morphine—Galantamine—BCHE—breast cancer	0.00021	0.0645	CrCbGaD
Morphine—Naloxone—ESR1—breast cancer	0.000205	0.0628	CrCbGaD
Morphine—Dihydrocodeine—CYP2D6—breast cancer	0.00019	0.0584	CrCbGaD
Morphine—CYP2C8—endocrine gland—breast cancer	0.000183	0.0119	CbGeAlD
Morphine—Hydromorphone—PTGS1—breast cancer	0.000178	0.0545	CrCbGaD
Morphine—ABCB1—embryo—breast cancer	0.000171	0.0111	CbGeAlD
Morphine—Oxymorphone—CYP2D6—breast cancer	0.000167	0.0512	CrCbGaD
Morphine—Dihydrocodeine—CYP3A4—breast cancer	0.000163	0.0501	CrCbGaD
Morphine—Ethylmorphine—CYP2D6—breast cancer	0.00016	0.049	CrCbGaD
Morphine—CYP3A4—female reproductive system—breast cancer	0.000147	0.00955	CbGeAlD
Morphine—Hydrocodone—CYP2D6—breast cancer	0.000146	0.0448	CrCbGaD
Morphine—CYP2D6—female reproductive system—breast cancer	0.000144	0.00939	CbGeAlD
Morphine—Oxymorphone—CYP3A4—breast cancer	0.000143	0.044	CrCbGaD
Morphine—ABCB1—epithelium—breast cancer	0.00014	0.0091	CbGeAlD
Morphine—Ethylmorphine—CYP3A4—breast cancer	0.000137	0.042	CrCbGaD
Morphine—CYP2D6—female gonad—breast cancer	0.000131	0.00855	CbGeAlD
Morphine—Codeine—CYP2D6—breast cancer	0.000127	0.039	CrCbGaD
Morphine—ABCB1—endometrium—breast cancer	0.000125	0.00816	CbGeAlD
Morphine—Hydrocodone—CYP3A4—breast cancer	0.000125	0.0384	CrCbGaD
Morphine—CYP3A4—endocrine gland—breast cancer	0.000124	0.00808	CbGeAlD
Morphine—CYP2D6—endocrine gland—breast cancer	0.000122	0.00795	CbGeAlD
Morphine—Hydromorphone—CYP2D6—breast cancer	0.000121	0.0371	CrCbGaD
Morphine—Naltrexone—ABCB1—breast cancer	0.000119	0.0366	CrCbGaD
Morphine—ABCB1—uterus—breast cancer	0.000116	0.00752	CbGeAlD
Morphine—Galantamine—CYP2D6—breast cancer	0.000115	0.0354	CrCbGaD
Morphine—ABCB1—pituitary gland—breast cancer	0.000113	0.00738	CbGeAlD
Morphine—ABCB1—adipose tissue—breast cancer	0.000113	0.00735	CbGeAlD
Morphine—Codeine—CYP3A4—breast cancer	0.000109	0.0334	CrCbGaD
Morphine—Naloxone—CYP3A4—breast cancer	0.000105	0.0321	CrCbGaD
Morphine—ABCB1—female reproductive system—breast cancer	0.000104	0.00676	CbGeAlD
Morphine—Hydromorphone—CYP3A4—breast cancer	0.000104	0.0318	CrCbGaD
Morphine—ABCB1—adrenal gland—breast cancer	0.000101	0.00659	CbGeAlD
Morphine—Galantamine—CYP3A4—breast cancer	9.9e-05	0.0304	CrCbGaD
Morphine—ABCB1—bone marrow—breast cancer	9.81e-05	0.00638	CbGeAlD
Morphine—ABCB1—female gonad—breast cancer	9.45e-05	0.00615	CbGeAlD
Morphine—Naloxone—ALB—breast cancer	9.12e-05	0.028	CrCbGaD
Morphine—ABCB1—endocrine gland—breast cancer	8.79e-05	0.00572	CbGeAlD
Morphine—Naloxone—ABCB1—breast cancer	8.7e-05	0.0267	CrCbGaD
Morphine—ABCB1—lymph node—breast cancer	6.08e-05	0.00395	CbGeAlD
Morphine—Paraesthesia—Capecitabine—breast cancer	2.8e-05	0.000147	CcSEcCtD
Morphine—Decreased appetite—Docetaxel—breast cancer	2.8e-05	0.000147	CcSEcCtD
Morphine—Hypersensitivity—Paclitaxel—breast cancer	2.8e-05	0.000147	CcSEcCtD
Morphine—Headache—Fluorouracil—breast cancer	2.79e-05	0.000147	CcSEcCtD
Morphine—Urinary tract disorder—Doxorubicin—breast cancer	2.79e-05	0.000147	CcSEcCtD
Morphine—Oedema peripheral—Doxorubicin—breast cancer	2.78e-05	0.000146	CcSEcCtD
Morphine—Dysgeusia—Methotrexate—breast cancer	2.78e-05	0.000146	CcSEcCtD
Morphine—Gastrointestinal disorder—Docetaxel—breast cancer	2.78e-05	0.000146	CcSEcCtD
Morphine—Connective tissue disorder—Doxorubicin—breast cancer	2.78e-05	0.000146	CcSEcCtD
Morphine—Dyspnoea—Capecitabine—breast cancer	2.78e-05	0.000146	CcSEcCtD
Morphine—Fatigue—Docetaxel—breast cancer	2.77e-05	0.000146	CcSEcCtD
Morphine—Angiopathy—Epirubicin—breast cancer	2.77e-05	0.000146	CcSEcCtD
Morphine—Urethral disorder—Doxorubicin—breast cancer	2.77e-05	0.000146	CcSEcCtD
Morphine—Nausea—Mitoxantrone—breast cancer	2.76e-05	0.000145	CcSEcCtD
Morphine—Nausea—Irinotecan—breast cancer	2.76e-05	0.000145	CcSEcCtD
Morphine—Mediastinal disorder—Epirubicin—breast cancer	2.75e-05	0.000145	CcSEcCtD
Morphine—Pain—Docetaxel—breast cancer	2.75e-05	0.000145	CcSEcCtD
Morphine—Constipation—Docetaxel—breast cancer	2.75e-05	0.000145	CcSEcCtD
Morphine—Back pain—Methotrexate—breast cancer	2.75e-05	0.000145	CcSEcCtD
Morphine—Dyspepsia—Capecitabine—breast cancer	2.74e-05	0.000144	CcSEcCtD
Morphine—Chills—Epirubicin—breast cancer	2.74e-05	0.000144	CcSEcCtD
Morphine—Visual impairment—Doxorubicin—breast cancer	2.72e-05	0.000143	CcSEcCtD
Morphine—Asthenia—Paclitaxel—breast cancer	2.72e-05	0.000143	CcSEcCtD
Morphine—Decreased appetite—Capecitabine—breast cancer	2.71e-05	0.000142	CcSEcCtD
Morphine—Nausea—Gemcitabine—breast cancer	2.69e-05	0.000142	CcSEcCtD
Morphine—Gastrointestinal disorder—Capecitabine—breast cancer	2.69e-05	0.000141	CcSEcCtD
Morphine—Fatigue—Capecitabine—breast cancer	2.69e-05	0.000141	CcSEcCtD
Morphine—Pruritus—Paclitaxel—breast cancer	2.69e-05	0.000141	CcSEcCtD
Morphine—Vision blurred—Methotrexate—breast cancer	2.68e-05	0.000141	CcSEcCtD
Morphine—Mental disorder—Epirubicin—breast cancer	2.68e-05	0.000141	CcSEcCtD
Morphine—Constipation—Capecitabine—breast cancer	2.66e-05	0.00014	CcSEcCtD
Morphine—Pain—Capecitabine—breast cancer	2.66e-05	0.00014	CcSEcCtD
Morphine—Malnutrition—Epirubicin—breast cancer	2.66e-05	0.00014	CcSEcCtD
Morphine—Erythema—Epirubicin—breast cancer	2.66e-05	0.00014	CcSEcCtD
Morphine—Feeling abnormal—Docetaxel—breast cancer	2.65e-05	0.000139	CcSEcCtD
Morphine—Nausea—Fluorouracil—breast cancer	2.65e-05	0.000139	CcSEcCtD
Morphine—Eye disorder—Doxorubicin—breast cancer	2.64e-05	0.000139	CcSEcCtD
Morphine—Ill-defined disorder—Methotrexate—breast cancer	2.64e-05	0.000139	CcSEcCtD
Morphine—Gastrointestinal pain—Docetaxel—breast cancer	2.63e-05	0.000138	CcSEcCtD
Morphine—Anaemia—Methotrexate—breast cancer	2.63e-05	0.000138	CcSEcCtD
Morphine—Flushing—Doxorubicin—breast cancer	2.62e-05	0.000138	CcSEcCtD
Morphine—Flatulence—Epirubicin—breast cancer	2.62e-05	0.000138	CcSEcCtD
Morphine—Tension—Epirubicin—breast cancer	2.61e-05	0.000137	CcSEcCtD
Morphine—Dysgeusia—Epirubicin—breast cancer	2.6e-05	0.000137	CcSEcCtD
Morphine—Diarrhoea—Paclitaxel—breast cancer	2.6e-05	0.000137	CcSEcCtD
Morphine—Nervousness—Epirubicin—breast cancer	2.58e-05	0.000136	CcSEcCtD
Morphine—Back pain—Epirubicin—breast cancer	2.57e-05	0.000135	CcSEcCtD
Morphine—Feeling abnormal—Capecitabine—breast cancer	2.57e-05	0.000135	CcSEcCtD
Morphine—Angiopathy—Doxorubicin—breast cancer	2.56e-05	0.000135	CcSEcCtD
Morphine—Malaise—Methotrexate—breast cancer	2.56e-05	0.000135	CcSEcCtD
Morphine—Muscle spasms—Epirubicin—breast cancer	2.56e-05	0.000134	CcSEcCtD
Morphine—Vertigo—Methotrexate—breast cancer	2.55e-05	0.000134	CcSEcCtD
Morphine—Gastrointestinal pain—Capecitabine—breast cancer	2.55e-05	0.000134	CcSEcCtD
Morphine—Mediastinal disorder—Doxorubicin—breast cancer	2.55e-05	0.000134	CcSEcCtD
Morphine—Abdominal pain—Docetaxel—breast cancer	2.54e-05	0.000134	CcSEcCtD
Morphine—Body temperature increased—Docetaxel—breast cancer	2.54e-05	0.000134	CcSEcCtD
Morphine—Leukopenia—Methotrexate—breast cancer	2.54e-05	0.000134	CcSEcCtD
Morphine—Chills—Doxorubicin—breast cancer	2.54e-05	0.000133	CcSEcCtD
Morphine—Dizziness—Paclitaxel—breast cancer	2.51e-05	0.000132	CcSEcCtD
Morphine—Vision blurred—Epirubicin—breast cancer	2.51e-05	0.000132	CcSEcCtD
Morphine—Cough—Methotrexate—breast cancer	2.48e-05	0.00013	CcSEcCtD
Morphine—Mental disorder—Doxorubicin—breast cancer	2.48e-05	0.00013	CcSEcCtD
Morphine—Urticaria—Capecitabine—breast cancer	2.47e-05	0.00013	CcSEcCtD
Morphine—Ill-defined disorder—Epirubicin—breast cancer	2.47e-05	0.00013	CcSEcCtD
Morphine—Abdominal pain—Capecitabine—breast cancer	2.46e-05	0.00013	CcSEcCtD
Morphine—Body temperature increased—Capecitabine—breast cancer	2.46e-05	0.00013	CcSEcCtD
Morphine—Convulsion—Methotrexate—breast cancer	2.46e-05	0.000129	CcSEcCtD
Morphine—Malnutrition—Doxorubicin—breast cancer	2.46e-05	0.000129	CcSEcCtD
Morphine—Erythema—Doxorubicin—breast cancer	2.46e-05	0.000129	CcSEcCtD
Morphine—Anaemia—Epirubicin—breast cancer	2.46e-05	0.000129	CcSEcCtD
Morphine—Agitation—Epirubicin—breast cancer	2.44e-05	0.000129	CcSEcCtD
Morphine—Flatulence—Doxorubicin—breast cancer	2.42e-05	0.000128	CcSEcCtD
Morphine—Arthralgia—Methotrexate—breast cancer	2.42e-05	0.000127	CcSEcCtD
Morphine—Chest pain—Methotrexate—breast cancer	2.42e-05	0.000127	CcSEcCtD
Morphine—Tension—Doxorubicin—breast cancer	2.41e-05	0.000127	CcSEcCtD
Morphine—Vomiting—Paclitaxel—breast cancer	2.41e-05	0.000127	CcSEcCtD
Morphine—Dysgeusia—Doxorubicin—breast cancer	2.41e-05	0.000127	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.4e-05	0.000126	CcSEcCtD
Morphine—Malaise—Epirubicin—breast cancer	2.4e-05	0.000126	CcSEcCtD
Morphine—Rash—Paclitaxel—breast cancer	2.39e-05	0.000126	CcSEcCtD
Morphine—Dermatitis—Paclitaxel—breast cancer	2.39e-05	0.000126	CcSEcCtD
Morphine—Discomfort—Methotrexate—breast cancer	2.39e-05	0.000126	CcSEcCtD
Morphine—Nervousness—Doxorubicin—breast cancer	2.39e-05	0.000126	CcSEcCtD
Morphine—Vertigo—Epirubicin—breast cancer	2.39e-05	0.000126	CcSEcCtD
Morphine—Syncope—Epirubicin—breast cancer	2.38e-05	0.000125	CcSEcCtD
Morphine—Leukopenia—Epirubicin—breast cancer	2.38e-05	0.000125	CcSEcCtD
Morphine—Back pain—Doxorubicin—breast cancer	2.38e-05	0.000125	CcSEcCtD
Morphine—Headache—Paclitaxel—breast cancer	2.38e-05	0.000125	CcSEcCtD
Morphine—Hypersensitivity—Docetaxel—breast cancer	2.37e-05	0.000125	CcSEcCtD
Morphine—Muscle spasms—Doxorubicin—breast cancer	2.37e-05	0.000124	CcSEcCtD
Morphine—Palpitations—Epirubicin—breast cancer	2.35e-05	0.000124	CcSEcCtD
Morphine—Confusional state—Methotrexate—breast cancer	2.34e-05	0.000123	CcSEcCtD
Morphine—Loss of consciousness—Epirubicin—breast cancer	2.34e-05	0.000123	CcSEcCtD
Morphine—Cough—Epirubicin—breast cancer	2.32e-05	0.000122	CcSEcCtD
Morphine—Anaphylactic shock—Methotrexate—breast cancer	2.32e-05	0.000122	CcSEcCtD
Morphine—Vision blurred—Doxorubicin—breast cancer	2.32e-05	0.000122	CcSEcCtD
Morphine—Asthenia—Docetaxel—breast cancer	2.31e-05	0.000121	CcSEcCtD
Morphine—Convulsion—Epirubicin—breast cancer	2.3e-05	0.000121	CcSEcCtD
Morphine—Infection—Methotrexate—breast cancer	2.3e-05	0.000121	CcSEcCtD
Morphine—Hypertension—Epirubicin—breast cancer	2.3e-05	0.000121	CcSEcCtD
Morphine—Hypersensitivity—Capecitabine—breast cancer	2.29e-05	0.000121	CcSEcCtD
Morphine—Ill-defined disorder—Doxorubicin—breast cancer	2.28e-05	0.00012	CcSEcCtD
Morphine—Pruritus—Docetaxel—breast cancer	2.28e-05	0.00012	CcSEcCtD
Morphine—Nervous system disorder—Methotrexate—breast cancer	2.27e-05	0.00012	CcSEcCtD
Morphine—Anaemia—Doxorubicin—breast cancer	2.27e-05	0.00012	CcSEcCtD
Morphine—Thrombocytopenia—Methotrexate—breast cancer	2.27e-05	0.000119	CcSEcCtD
Morphine—Arthralgia—Epirubicin—breast cancer	2.26e-05	0.000119	CcSEcCtD
Morphine—Chest pain—Epirubicin—breast cancer	2.26e-05	0.000119	CcSEcCtD
Morphine—Agitation—Doxorubicin—breast cancer	2.26e-05	0.000119	CcSEcCtD
Morphine—Anxiety—Epirubicin—breast cancer	2.26e-05	0.000119	CcSEcCtD
Morphine—Nausea—Paclitaxel—breast cancer	2.25e-05	0.000119	CcSEcCtD
Morphine—Skin disorder—Methotrexate—breast cancer	2.25e-05	0.000118	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.25e-05	0.000118	CcSEcCtD
Morphine—Hyperhidrosis—Methotrexate—breast cancer	2.24e-05	0.000118	CcSEcCtD
Morphine—Discomfort—Epirubicin—breast cancer	2.24e-05	0.000118	CcSEcCtD
Morphine—Asthenia—Capecitabine—breast cancer	2.23e-05	0.000118	CcSEcCtD
Morphine—Malaise—Doxorubicin—breast cancer	2.22e-05	0.000117	CcSEcCtD
Morphine—Dry mouth—Epirubicin—breast cancer	2.21e-05	0.000116	CcSEcCtD
Morphine—Vertigo—Doxorubicin—breast cancer	2.21e-05	0.000116	CcSEcCtD
Morphine—Anorexia—Methotrexate—breast cancer	2.21e-05	0.000116	CcSEcCtD
Morphine—Syncope—Doxorubicin—breast cancer	2.21e-05	0.000116	CcSEcCtD
Morphine—Pruritus—Capecitabine—breast cancer	2.2e-05	0.000116	CcSEcCtD
Morphine—Leukopenia—Doxorubicin—breast cancer	2.2e-05	0.000116	CcSEcCtD
Morphine—Diarrhoea—Docetaxel—breast cancer	2.2e-05	0.000116	CcSEcCtD
Morphine—Confusional state—Epirubicin—breast cancer	2.19e-05	0.000115	CcSEcCtD
Morphine—Palpitations—Doxorubicin—breast cancer	2.17e-05	0.000114	CcSEcCtD
Morphine—Oedema—Epirubicin—breast cancer	2.17e-05	0.000114	CcSEcCtD
Morphine—Anaphylactic shock—Epirubicin—breast cancer	2.17e-05	0.000114	CcSEcCtD
Morphine—Hypotension—Methotrexate—breast cancer	2.17e-05	0.000114	CcSEcCtD
Morphine—Loss of consciousness—Doxorubicin—breast cancer	2.16e-05	0.000114	CcSEcCtD
Morphine—Infection—Epirubicin—breast cancer	2.16e-05	0.000113	CcSEcCtD
Morphine—Cough—Doxorubicin—breast cancer	2.15e-05	0.000113	CcSEcCtD
Morphine—Shock—Epirubicin—breast cancer	2.13e-05	0.000112	CcSEcCtD
Morphine—Convulsion—Doxorubicin—breast cancer	2.13e-05	0.000112	CcSEcCtD
Morphine—Diarrhoea—Capecitabine—breast cancer	2.13e-05	0.000112	CcSEcCtD
Morphine—Nervous system disorder—Epirubicin—breast cancer	2.13e-05	0.000112	CcSEcCtD
Morphine—Dizziness—Docetaxel—breast cancer	2.13e-05	0.000112	CcSEcCtD
Morphine—Thrombocytopenia—Epirubicin—breast cancer	2.12e-05	0.000112	CcSEcCtD
Morphine—Hypertension—Doxorubicin—breast cancer	2.12e-05	0.000112	CcSEcCtD
Morphine—Tachycardia—Epirubicin—breast cancer	2.12e-05	0.000111	CcSEcCtD
Morphine—Musculoskeletal discomfort—Methotrexate—breast cancer	2.11e-05	0.000111	CcSEcCtD
Morphine—Skin disorder—Epirubicin—breast cancer	2.11e-05	0.000111	CcSEcCtD
Morphine—Hyperhidrosis—Epirubicin—breast cancer	2.1e-05	0.00011	CcSEcCtD
Morphine—Insomnia—Methotrexate—breast cancer	2.1e-05	0.00011	CcSEcCtD
Morphine—Arthralgia—Doxorubicin—breast cancer	2.09e-05	0.00011	CcSEcCtD
Morphine—Chest pain—Doxorubicin—breast cancer	2.09e-05	0.00011	CcSEcCtD
Morphine—Anxiety—Doxorubicin—breast cancer	2.09e-05	0.00011	CcSEcCtD
Morphine—Paraesthesia—Methotrexate—breast cancer	2.08e-05	0.00011	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.08e-05	0.000109	CcSEcCtD
Morphine—Discomfort—Doxorubicin—breast cancer	2.07e-05	0.000109	CcSEcCtD
Morphine—Anorexia—Epirubicin—breast cancer	2.07e-05	0.000109	CcSEcCtD
Morphine—Dyspnoea—Methotrexate—breast cancer	2.07e-05	0.000109	CcSEcCtD
Morphine—Somnolence—Methotrexate—breast cancer	2.06e-05	0.000108	CcSEcCtD
Morphine—Dizziness—Capecitabine—breast cancer	2.06e-05	0.000108	CcSEcCtD
Morphine—Dry mouth—Doxorubicin—breast cancer	2.05e-05	0.000108	CcSEcCtD
Morphine—Vomiting—Docetaxel—breast cancer	2.05e-05	0.000108	CcSEcCtD
Morphine—Dyspepsia—Methotrexate—breast cancer	2.04e-05	0.000107	CcSEcCtD
Morphine—Rash—Docetaxel—breast cancer	2.03e-05	0.000107	CcSEcCtD
Morphine—Hypotension—Epirubicin—breast cancer	2.03e-05	0.000107	CcSEcCtD
Morphine—Dermatitis—Docetaxel—breast cancer	2.03e-05	0.000107	CcSEcCtD
Morphine—Confusional state—Doxorubicin—breast cancer	2.02e-05	0.000106	CcSEcCtD
Morphine—Decreased appetite—Methotrexate—breast cancer	2.02e-05	0.000106	CcSEcCtD
Morphine—Headache—Docetaxel—breast cancer	2.02e-05	0.000106	CcSEcCtD
Morphine—Anaphylactic shock—Doxorubicin—breast cancer	2.01e-05	0.000106	CcSEcCtD
Morphine—Oedema—Doxorubicin—breast cancer	2.01e-05	0.000106	CcSEcCtD
Morphine—Gastrointestinal disorder—Methotrexate—breast cancer	2e-05	0.000105	CcSEcCtD
Morphine—Fatigue—Methotrexate—breast cancer	2e-05	0.000105	CcSEcCtD
Morphine—Infection—Doxorubicin—breast cancer	1.99e-05	0.000105	CcSEcCtD
Morphine—Pain—Methotrexate—breast cancer	1.98e-05	0.000104	CcSEcCtD
Morphine—Vomiting—Capecitabine—breast cancer	1.98e-05	0.000104	CcSEcCtD
Morphine—Musculoskeletal discomfort—Epirubicin—breast cancer	1.98e-05	0.000104	CcSEcCtD
Morphine—Shock—Doxorubicin—breast cancer	1.98e-05	0.000104	CcSEcCtD
Morphine—Nervous system disorder—Doxorubicin—breast cancer	1.97e-05	0.000104	CcSEcCtD
Morphine—Thrombocytopenia—Doxorubicin—breast cancer	1.97e-05	0.000103	CcSEcCtD
Morphine—Rash—Capecitabine—breast cancer	1.96e-05	0.000103	CcSEcCtD
Morphine—Insomnia—Epirubicin—breast cancer	1.96e-05	0.000103	CcSEcCtD
Morphine—Dermatitis—Capecitabine—breast cancer	1.96e-05	0.000103	CcSEcCtD
Morphine—Tachycardia—Doxorubicin—breast cancer	1.96e-05	0.000103	CcSEcCtD
Morphine—Headache—Capecitabine—breast cancer	1.95e-05	0.000103	CcSEcCtD
Morphine—Skin disorder—Doxorubicin—breast cancer	1.95e-05	0.000103	CcSEcCtD
Morphine—Paraesthesia—Epirubicin—breast cancer	1.95e-05	0.000102	CcSEcCtD
Morphine—Hyperhidrosis—Doxorubicin—breast cancer	1.94e-05	0.000102	CcSEcCtD
Morphine—Dyspnoea—Epirubicin—breast cancer	1.93e-05	0.000102	CcSEcCtD
Morphine—Somnolence—Epirubicin—breast cancer	1.93e-05	0.000101	CcSEcCtD
Morphine—Anorexia—Doxorubicin—breast cancer	1.91e-05	0.000101	CcSEcCtD
Morphine—Nausea—Docetaxel—breast cancer	1.91e-05	0.000101	CcSEcCtD
Morphine—Feeling abnormal—Methotrexate—breast cancer	1.91e-05	0.0001	CcSEcCtD
Morphine—Dyspepsia—Epirubicin—breast cancer	1.91e-05	0.0001	CcSEcCtD
Morphine—Gastrointestinal pain—Methotrexate—breast cancer	1.9e-05	9.97e-05	CcSEcCtD
Morphine—Decreased appetite—Epirubicin—breast cancer	1.89e-05	9.92e-05	CcSEcCtD
Morphine—Hypotension—Doxorubicin—breast cancer	1.88e-05	9.87e-05	CcSEcCtD
Morphine—Gastrointestinal disorder—Epirubicin—breast cancer	1.87e-05	9.85e-05	CcSEcCtD
Morphine—Fatigue—Epirubicin—breast cancer	1.87e-05	9.84e-05	CcSEcCtD
Morphine—Constipation—Epirubicin—breast cancer	1.86e-05	9.76e-05	CcSEcCtD
Morphine—Pain—Epirubicin—breast cancer	1.86e-05	9.76e-05	CcSEcCtD
Morphine—Nausea—Capecitabine—breast cancer	1.85e-05	9.73e-05	CcSEcCtD
Morphine—Urticaria—Methotrexate—breast cancer	1.84e-05	9.69e-05	CcSEcCtD
Morphine—Abdominal pain—Methotrexate—breast cancer	1.83e-05	9.64e-05	CcSEcCtD
Morphine—Body temperature increased—Methotrexate—breast cancer	1.83e-05	9.64e-05	CcSEcCtD
Morphine—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.83e-05	9.62e-05	CcSEcCtD
Morphine—Insomnia—Doxorubicin—breast cancer	1.82e-05	9.55e-05	CcSEcCtD
Morphine—Paraesthesia—Doxorubicin—breast cancer	1.8e-05	9.48e-05	CcSEcCtD
Morphine—Dyspnoea—Doxorubicin—breast cancer	1.79e-05	9.41e-05	CcSEcCtD
Morphine—Feeling abnormal—Epirubicin—breast cancer	1.79e-05	9.4e-05	CcSEcCtD
Morphine—Somnolence—Doxorubicin—breast cancer	1.78e-05	9.39e-05	CcSEcCtD
Morphine—Gastrointestinal pain—Epirubicin—breast cancer	1.77e-05	9.33e-05	CcSEcCtD
Morphine—Dyspepsia—Doxorubicin—breast cancer	1.77e-05	9.3e-05	CcSEcCtD
Morphine—Decreased appetite—Doxorubicin—breast cancer	1.75e-05	9.18e-05	CcSEcCtD
Morphine—Gastrointestinal disorder—Doxorubicin—breast cancer	1.73e-05	9.12e-05	CcSEcCtD
Morphine—Fatigue—Doxorubicin—breast cancer	1.73e-05	9.1e-05	CcSEcCtD
Morphine—Urticaria—Epirubicin—breast cancer	1.72e-05	9.07e-05	CcSEcCtD
Morphine—Pain—Doxorubicin—breast cancer	1.72e-05	9.03e-05	CcSEcCtD
Morphine—Constipation—Doxorubicin—breast cancer	1.72e-05	9.03e-05	CcSEcCtD
Morphine—Abdominal pain—Epirubicin—breast cancer	1.72e-05	9.02e-05	CcSEcCtD
Morphine—Body temperature increased—Epirubicin—breast cancer	1.72e-05	9.02e-05	CcSEcCtD
Morphine—Hypersensitivity—Methotrexate—breast cancer	1.71e-05	8.99e-05	CcSEcCtD
Morphine—Asthenia—Methotrexate—breast cancer	1.66e-05	8.75e-05	CcSEcCtD
Morphine—Feeling abnormal—Doxorubicin—breast cancer	1.65e-05	8.7e-05	CcSEcCtD
Morphine—Gastrointestinal pain—Doxorubicin—breast cancer	1.64e-05	8.64e-05	CcSEcCtD
Morphine—Pruritus—Methotrexate—breast cancer	1.64e-05	8.63e-05	CcSEcCtD
Morphine—Hypersensitivity—Epirubicin—breast cancer	1.6e-05	8.41e-05	CcSEcCtD
Morphine—Urticaria—Doxorubicin—breast cancer	1.59e-05	8.39e-05	CcSEcCtD
Morphine—Abdominal pain—Doxorubicin—breast cancer	1.59e-05	8.35e-05	CcSEcCtD
Morphine—Body temperature increased—Doxorubicin—breast cancer	1.59e-05	8.35e-05	CcSEcCtD
Morphine—Diarrhoea—Methotrexate—breast cancer	1.59e-05	8.34e-05	CcSEcCtD
Morphine—Asthenia—Epirubicin—breast cancer	1.56e-05	8.19e-05	CcSEcCtD
Morphine—Pruritus—Epirubicin—breast cancer	1.54e-05	8.07e-05	CcSEcCtD
Morphine—Dizziness—Methotrexate—breast cancer	1.53e-05	8.06e-05	CcSEcCtD
Morphine—Diarrhoea—Epirubicin—breast cancer	1.48e-05	7.81e-05	CcSEcCtD
Morphine—Hypersensitivity—Doxorubicin—breast cancer	1.48e-05	7.78e-05	CcSEcCtD
Morphine—Vomiting—Methotrexate—breast cancer	1.47e-05	7.75e-05	CcSEcCtD
Morphine—Rash—Methotrexate—breast cancer	1.46e-05	7.69e-05	CcSEcCtD
Morphine—Dermatitis—Methotrexate—breast cancer	1.46e-05	7.68e-05	CcSEcCtD
Morphine—Headache—Methotrexate—breast cancer	1.45e-05	7.64e-05	CcSEcCtD
Morphine—Asthenia—Doxorubicin—breast cancer	1.44e-05	7.58e-05	CcSEcCtD
Morphine—Dizziness—Epirubicin—breast cancer	1.43e-05	7.55e-05	CcSEcCtD
Morphine—Pruritus—Doxorubicin—breast cancer	1.42e-05	7.47e-05	CcSEcCtD
Morphine—Vomiting—Epirubicin—breast cancer	1.38e-05	7.26e-05	CcSEcCtD
Morphine—Nausea—Methotrexate—breast cancer	1.38e-05	7.24e-05	CcSEcCtD
Morphine—Diarrhoea—Doxorubicin—breast cancer	1.37e-05	7.23e-05	CcSEcCtD
Morphine—Rash—Epirubicin—breast cancer	1.37e-05	7.2e-05	CcSEcCtD
Morphine—Dermatitis—Epirubicin—breast cancer	1.37e-05	7.19e-05	CcSEcCtD
Morphine—Headache—Epirubicin—breast cancer	1.36e-05	7.15e-05	CcSEcCtD
Morphine—Dizziness—Doxorubicin—breast cancer	1.33e-05	6.98e-05	CcSEcCtD
Morphine—Nausea—Epirubicin—breast cancer	1.29e-05	6.78e-05	CcSEcCtD
Morphine—Vomiting—Doxorubicin—breast cancer	1.28e-05	6.71e-05	CcSEcCtD
Morphine—Rash—Doxorubicin—breast cancer	1.27e-05	6.66e-05	CcSEcCtD
Morphine—Dermatitis—Doxorubicin—breast cancer	1.26e-05	6.65e-05	CcSEcCtD
Morphine—Headache—Doxorubicin—breast cancer	1.26e-05	6.62e-05	CcSEcCtD
Morphine—Nausea—Doxorubicin—breast cancer	1.19e-05	6.27e-05	CcSEcCtD
Morphine—OPRM1—Signaling by GPCR—MAPK3—breast cancer	2.7e-06	2.19e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.7e-06	2.19e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTA1—breast cancer	2.69e-06	2.18e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—IDH1—breast cancer	2.69e-06	2.18e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CASP3—breast cancer	2.68e-06	2.17e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL2—breast cancer	2.68e-06	2.17e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—COMT—breast cancer	2.68e-06	2.17e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1B1—breast cancer	2.67e-06	2.16e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL6—breast cancer	2.67e-06	2.16e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTP1—breast cancer	2.66e-06	2.16e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NAT2—breast cancer	2.66e-06	2.15e-05	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	2.65e-06	2.15e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—BRAF—breast cancer	2.65e-06	2.15e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CB—breast cancer	2.65e-06	2.14e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CA—breast cancer	2.64e-06	2.14e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MDM2—breast cancer	2.63e-06	2.13e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HMOX1—breast cancer	2.63e-06	2.13e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC2A1—breast cancer	2.62e-06	2.12e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NQO1—breast cancer	2.62e-06	2.12e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ITPR1—breast cancer	2.62e-06	2.12e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RAF1—breast cancer	2.62e-06	2.12e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—breast cancer	2.62e-06	2.12e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HSP90AA1—breast cancer	2.62e-06	2.12e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCND1—breast cancer	2.61e-06	2.12e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RELA—breast cancer	2.61e-06	2.11e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—JUN—breast cancer	2.61e-06	2.11e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ERBB2—breast cancer	2.59e-06	2.1e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CTNNB1—breast cancer	2.59e-06	2.09e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF1—breast cancer	2.58e-06	2.09e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT2—breast cancer	2.58e-06	2.09e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—breast cancer	2.57e-06	2.08e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CB—breast cancer	2.56e-06	2.07e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MTOR—breast cancer	2.56e-06	2.07e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP3A4—breast cancer	2.56e-06	2.07e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NCOA1—breast cancer	2.55e-06	2.06e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—breast cancer	2.54e-06	2.05e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1A—breast cancer	2.53e-06	2.05e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTEN—breast cancer	2.52e-06	2.04e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ABCB1—breast cancer	2.52e-06	2.04e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1B1—breast cancer	2.51e-06	2.04e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP19A1—breast cancer	2.51e-06	2.03e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—STK11—breast cancer	2.51e-06	2.03e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CD—breast cancer	2.48e-06	2.01e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TYMS—breast cancer	2.48e-06	2.01e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK8—breast cancer	2.47e-06	2e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.47e-06	2e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—breast cancer	2.46e-06	1.99e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL8—breast cancer	2.46e-06	1.99e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	2.46e-06	1.99e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SERPINE1—breast cancer	2.45e-06	1.99e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.45e-06	1.98e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTM1—breast cancer	2.45e-06	1.98e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NCOR1—breast cancer	2.45e-06	1.98e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HRAS—breast cancer	2.44e-06	1.98e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KRAS—breast cancer	2.43e-06	1.97e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1B—breast cancer	2.4e-06	1.94e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NCOA1—breast cancer	2.4e-06	1.94e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—breast cancer	2.38e-06	1.92e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—STK11—breast cancer	2.36e-06	1.91e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP19A1—breast cancer	2.36e-06	1.91e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CASP3—breast cancer	2.35e-06	1.91e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL2—breast cancer	2.35e-06	1.9e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GPX1—breast cancer	2.34e-06	1.9e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOS3—breast cancer	2.34e-06	1.9e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SRC—breast cancer	2.34e-06	1.89e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL6—breast cancer	2.34e-06	1.89e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CA—breast cancer	2.33e-06	1.89e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MED12—breast cancer	2.33e-06	1.89e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—DPYD—breast cancer	2.33e-06	1.89e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—COMT—breast cancer	2.33e-06	1.89e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTP1—breast cancer	2.32e-06	1.88e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP1A1—breast cancer	2.32e-06	1.88e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ERCC2—breast cancer	2.3e-06	1.86e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALDOA—breast cancer	2.3e-06	1.86e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCND1—breast cancer	2.29e-06	1.85e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HMOX1—breast cancer	2.29e-06	1.85e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—JUN—breast cancer	2.29e-06	1.85e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTEN—breast cancer	2.29e-06	1.85e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ITPR1—breast cancer	2.28e-06	1.85e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—breast cancer	2.28e-06	1.84e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CTNNB1—breast cancer	2.27e-06	1.84e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STAT3—breast cancer	2.26e-06	1.83e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	2.23e-06	1.81e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOA3—breast cancer	2.23e-06	1.8e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—breast cancer	2.22e-06	1.8e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MDM2—breast cancer	2.22e-06	1.8e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1A—breast cancer	2.22e-06	1.79e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RAF1—breast cancer	2.22e-06	1.79e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC2A2—breast cancer	2.21e-06	1.79e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTEN—breast cancer	2.21e-06	1.79e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RELA—breast cancer	2.21e-06	1.79e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—COMT—breast cancer	2.2e-06	1.78e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ERBB2—breast cancer	2.19e-06	1.77e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTP1—breast cancer	2.19e-06	1.77e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CPT1A—breast cancer	2.17e-06	1.76e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MTR—breast cancer	2.17e-06	1.76e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCG2—breast cancer	2.17e-06	1.76e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—MTHFR—breast cancer	2.16e-06	1.75e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK8—breast cancer	2.16e-06	1.75e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MTOR—breast cancer	2.16e-06	1.75e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CB—breast cancer	2.16e-06	1.75e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TYMS—breast cancer	2.16e-06	1.75e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—breast cancer	2.16e-06	1.75e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HMOX1—breast cancer	2.16e-06	1.75e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK3—breast cancer	2.16e-06	1.74e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ITPR1—breast cancer	2.15e-06	1.74e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PLA2G4A—breast cancer	2.13e-06	1.73e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTM1—breast cancer	2.13e-06	1.73e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NCOR1—breast cancer	2.13e-06	1.73e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HPGDS—breast cancer	2.13e-06	1.72e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HBA1—breast cancer	2.11e-06	1.71e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MYC—breast cancer	2.1e-06	1.7e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TGFB1—breast cancer	2.09e-06	1.69e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL8—breast cancer	2.08e-06	1.68e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ABCB1—breast cancer	2.07e-06	1.68e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HRAS—breast cancer	2.07e-06	1.67e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTT1—breast cancer	2.06e-06	1.67e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ACHE—breast cancer	2.06e-06	1.67e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SRC—breast cancer	2.05e-06	1.66e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—breast cancer	2.05e-06	1.66e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GPX1—breast cancer	2.04e-06	1.65e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TYMS—breast cancer	2.03e-06	1.65e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1B—breast cancer	2.03e-06	1.64e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1A1—breast cancer	2.02e-06	1.64e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.01e-06	1.63e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTM1—breast cancer	2.01e-06	1.63e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NCOR1—breast cancer	2.01e-06	1.63e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—breast cancer	2.01e-06	1.63e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ERCC2—breast cancer	2.01e-06	1.62e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—breast cancer	2e-06	1.62e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CAV1—breast cancer	2e-06	1.62e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CASP3—breast cancer	1.99e-06	1.61e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL2—breast cancer	1.99e-06	1.61e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CA—breast cancer	1.98e-06	1.61e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STAT3—breast cancer	1.98e-06	1.6e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL6—breast cancer	1.98e-06	1.6e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP17A1—breast cancer	1.95e-06	1.58e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KRAS—breast cancer	1.94e-06	1.57e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCND1—breast cancer	1.94e-06	1.57e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ENO1—breast cancer	1.93e-06	1.56e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS1—breast cancer	1.93e-06	1.56e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—JUN—breast cancer	1.93e-06	1.56e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GPX1—breast cancer	1.92e-06	1.56e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CTNNB1—breast cancer	1.92e-06	1.55e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.91e-06	1.54e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—breast cancer	1.91e-06	1.54e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1A1—breast cancer	1.91e-06	1.54e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP2D6—breast cancer	1.9e-06	1.53e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ERCC2—breast cancer	1.89e-06	1.53e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK3—breast cancer	1.89e-06	1.53e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—MTHFR—breast cancer	1.89e-06	1.53e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—breast cancer	1.88e-06	1.52e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1A—breast cancer	1.87e-06	1.52e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTEN—breast cancer	1.87e-06	1.51e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOA2—breast cancer	1.86e-06	1.51e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MYC—breast cancer	1.84e-06	1.49e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TGFB1—breast cancer	1.83e-06	1.48e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK8—breast cancer	1.83e-06	1.48e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—breast cancer	1.82e-06	1.48e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CG—breast cancer	1.82e-06	1.47e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—FASN—breast cancer	1.8e-06	1.46e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—breast cancer	1.8e-06	1.46e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—BCHE—breast cancer	1.8e-06	1.45e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CA—breast cancer	1.78e-06	1.44e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—MTHFR—breast cancer	1.78e-06	1.44e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC5A5—breast cancer	1.78e-06	1.44e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CAV1—breast cancer	1.74e-06	1.41e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SRC—breast cancer	1.73e-06	1.4e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—breast cancer	1.72e-06	1.39e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.71e-06	1.39e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NQO1—breast cancer	1.71e-06	1.39e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KRAS—breast cancer	1.7e-06	1.37e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—breast cancer	1.69e-06	1.37e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STAT3—breast cancer	1.67e-06	1.35e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HRAS—breast cancer	1.65e-06	1.33e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.64e-06	1.33e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CAV1—breast cancer	1.64e-06	1.33e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—breast cancer	1.62e-06	1.31e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CA—breast cancer	1.61e-06	1.31e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.61e-06	1.3e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CD—breast cancer	1.6e-06	1.29e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK3—breast cancer	1.6e-06	1.29e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CG—breast cancer	1.58e-06	1.28e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALB—breast cancer	1.58e-06	1.28e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6—breast cancer	1.58e-06	1.28e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOA1—breast cancer	1.57e-06	1.27e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CA—breast cancer	1.56e-06	1.26e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MYC—breast cancer	1.55e-06	1.26e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TGFB1—breast cancer	1.55e-06	1.25e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—STK11—breast cancer	1.55e-06	1.25e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.55e-06	1.25e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—breast cancer	1.52e-06	1.23e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—breast cancer	1.51e-06	1.22e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NOS3—breast cancer	1.51e-06	1.22e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.49e-06	1.21e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—breast cancer	1.45e-06	1.18e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HRAS—breast cancer	1.44e-06	1.17e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—COMT—breast cancer	1.44e-06	1.16e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KRAS—breast cancer	1.44e-06	1.16e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTP1—breast cancer	1.43e-06	1.16e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HMOX1—breast cancer	1.41e-06	1.14e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ITPR1—breast cancer	1.41e-06	1.14e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CB—breast cancer	1.39e-06	1.13e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CD—breast cancer	1.39e-06	1.13e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6—breast cancer	1.38e-06	1.12e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—breast cancer	1.38e-06	1.12e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALB—breast cancer	1.37e-06	1.11e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCB1—breast cancer	1.35e-06	1.1e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TYMS—breast cancer	1.33e-06	1.08e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CA—breast cancer	1.32e-06	1.07e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—breast cancer	1.32e-06	1.07e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NOS3—breast cancer	1.31e-06	1.06e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOR1—breast cancer	1.31e-06	1.06e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTM1—breast cancer	1.31e-06	1.06e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.31e-06	1.06e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.31e-06	1.06e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALB—breast cancer	1.3e-06	1.05e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—breast cancer	1.28e-06	1.03e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—breast cancer	1.27e-06	1.03e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GPX1—breast cancer	1.26e-06	1.02e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.25e-06	1.01e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NOS3—breast cancer	1.24e-06	1e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ERCC2—breast cancer	1.24e-06	1e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HRAS—breast cancer	1.22e-06	9.88e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CB—breast cancer	1.21e-06	9.82e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTEN—breast cancer	1.2e-06	9.74e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—breast cancer	1.2e-06	9.73e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6—breast cancer	1.17e-06	9.45e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MTHFR—breast cancer	1.16e-06	9.4e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.14e-06	9.26e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—breast cancer	1.13e-06	9.17e-06	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—breast cancer	1.08e-06	8.72e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CAV1—breast cancer	1.07e-06	8.67e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTEN—breast cancer	1.05e-06	8.49e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTEN—breast cancer	9.88e-07	8e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CG—breast cancer	9.76e-07	7.9e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CD—breast cancer	8.58e-07	6.94e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CA—breast cancer	8.49e-07	6.87e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALB—breast cancer	8.47e-07	6.85e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NOS3—breast cancer	8.1e-07	6.56e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CB—breast cancer	7.48e-07	6.05e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—breast cancer	7.41e-07	6e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CA—breast cancer	7.4e-07	5.99e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CA—breast cancer	6.97e-07	5.64e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—breast cancer	6.94e-07	5.62e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTEN—breast cancer	6.46e-07	5.23e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—breast cancer	6.04e-07	4.89e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—breast cancer	5.7e-07	4.61e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CA—breast cancer	4.56e-07	3.69e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—breast cancer	3.72e-07	3.01e-06	CbGpPWpGaD
